Bayer has become the latest in a long line of drug developers to give up on Huntington’s disease after the German pharma ...

Novavax, Inc. , a global company advancing protein-based vaccines with its Matrix-Mtm adjuvant, today announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold on ...

Mississauga: GSK's AREXVY (respiratory syncytial virus vaccine - recombinant, AS01E adjuvanted) has been approved in Canada ...

Developing a vaccination program for infectious bursal disease virus (IBDV) challenges should consider the severity and ...

The trial will be conducted in the Democratic Republic of the Congo in partnership with Emergent BioSolutions.

Disease surveillance and genomic analyses in northeast China identifies the emerging tick-borne Yezo virus in 2% of 988 ...

Loopworm is ramping up production at a facility in Bangalore capable of churning out 6,000t of silkworm and black soldier fly ...

Objectives Sjögren’s disease (SD) is an autoimmune disease affecting the exocrine glands that is associated with autoantibodies against Ro60/SS-A, anti-Ro52/TRIM21, La/SS-B and others. We examined the ...

Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart vaccines are designed to be administered using ...